FDA Drug Application (020747) for ACTIQ by CEPHALON

Back to FDA Applications sponsored by CEPHALON

Application Number020747
Product Number001
FormTROCHE/LOZENGE;TRANSMUCOSAL
DosageEQ 0.2MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameACTIQ
Active IngredientFENTANYL CITRATE

Active IngredientCount
List of drugs with Active Ingredient FENTANYL CITRATE11


Back to FDA Applications sponsored by CEPHALON